Rabies Vaccine bulk supplier for pharma manufacturers

Rabies Vaccine 2.5 IU Suppliers & Bulk Manufacturers

Available Forms: Lyophilized powder, Pre-filled syringes

Available Strengths: 2.5 IU

Reference Brands: Imovax Rabies(US), Abhayrab (India), Verorab (EU)

Category: Vaccines

Rabies vaccine stimulates immunity by introducing inactivated rabies virus, triggering the production of protective antibodies. It effectively prevents rabies infection, especially post-exposure. Benefits include lifelong protection, reducing fatalities, and controlling the spread of this deadly zoonotic disease through pre- and post-exposure prophylaxis.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Rabies vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves rigorous clinical evaluations, while in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and extensive audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective rabies prophylaxis programs worldwide, essential for travel, post-exposure treatment, and high-risk populations.

Rabies Vaccine — third party manufacturing & bulk supply

Rabies Vaccine 2.5 IU is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Rabies Vaccine is supplied as Lyophilized powder, Pre-filled syringes — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Rabies Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Rabies Vaccine →

Back to Listing

Frequently Asked Questions

Rabies Vaccine is used to prevent rabies infection caused by the rabies virus. It is administered both as pre-exposure prophylaxis for people at high risk of exposure and as post-exposure prophylaxis after a suspected animal bite or contact with a rabid animal to prevent the development of the disease.

Rabies vaccines are produced using inactivated (killed) rabies virus grown in cell culture systems such as human diploid cells, purified chick embryo cells, or Vero cells.

Common trade names include RabAvert, Imovax Rabies, Verorab, Rabipur, and Abhayrab.

Rabies vaccines are manufactured by several pharmaceutical companies including Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, Serum Institute of India, and Cadila Healthcare.

The generic name is rabies vaccine (inactivated).

Brand names include RabAvert, Imovax Rabies, Verorab, Rabipur, Abhayrab, and Indirab.

Rabies vaccines are manufactured in several countries including the United States, France, Germany, India, and other regions depending on the manufacturer.